PMID: 15340581Sep 2, 2004Paper

State of the Art Compendium: Canadian Thoracic Society recommendations for the management of chronic obstructive pulmonary disease

Canadian Respiratory Journal : Journal of the Canadian Thoracic Society
Denis E O'DonnellCanadian Thoracic Society

Abstract

Chronic obstructive pulmonary disease (COPD) is a common cause of disability and death in Canada. Moreover, morbidity and mortality from COPD continue to rise, and the economic burden is enormous. The main goal of the Canadian Thoracic Society's evidence-based guidelines is to optimize early diagnosis, prevention and management of COPD in Canada. The main message of the guidelines is that COPD is a preventable and treatable disease. Targeted spirometry is strongly recommended to expedite early diagnosis in smokers and former smokers who develop respiratory symptoms, and who are at risk for COPD. Smoking cessation remains the single most effective intervention to reduce the risk of COPD and to slow its progression. Education, especially self-management plans, are key interventions in COPD. Therapy should be escalated on an individual basis in accordance with the increasing severity of symptoms and disability. Long-acting anticholinergics and beta-2-agonist inhalers should be prescribed for patients who remain symptomatic despite short-acting bronchodilator therapy. Inhaled steroids should not be used as first line therapy in COPD, but have a role in preventing exacerbations in patients with more advanced disease who suffer recur...Continue Reading

Citations

Feb 10, 2007·Current Medical Research and Opinion·Mark GotfriedGerard F Notario
Jun 27, 2007·Journal of Palliative Medicine·Solomon Liao, Robert M Arnold
Apr 22, 2010·Current Opinion in Supportive and Palliative Care·Robert Horton, Graeme Rocker
Apr 26, 2011·COPD·Kathryn GaebelRon Goeree
Nov 16, 2016·Cells·Asma Yaghi, Myrna B Dolovich
Mar 30, 2006·Journal of Cardiopulmonary Rehabilitation·Renu GuptaDina Brooks
Jun 13, 2009·American Journal of Respiratory Cell and Molecular Biology·Pamela J PlantJane Batt
Sep 21, 2010·European Journal of Clinical Pharmacology·Sander D BorgsteedeMette L Rurup
May 7, 2010·Current Opinion in Supportive and Palliative Care·Robert HortonDavid Currow
Mar 21, 2009·Expert Review of Medical Devices·Jolyon P Mitchell, Mark W Nagel
Aug 2, 2008·QJM : Monthly Journal of the Association of Physicians·A C Simpson, G M Rocker
Jul 31, 2010·International Journal of Telemedicine and Applications·Michael StellefsonJ Don Chaney
Dec 16, 2005·Chest·Roger S Goldstein
Sep 18, 2007·Seminars in Thoracic and Cardiovascular Surgery·Edward P Ingenito

❮ Previous
Next ❯

Related Concepts

Related Feeds

Antifungals

An antifungal, also known as an antimycotic medication, is a pharmaceutical fungicide or fungistatic used to treat and prevent mycosis such as athlete's foot, ringworm, candidiasis, cryptococcal meningitis, and others. Discover the latest research on antifungals here.

Antifungals (ASM)

An antifungal, also known as an antimycotic medication, is a pharmaceutical fungicide or fungistatic used to treat and prevent mycosis such as athlete's foot, ringworm, candidiasis, cryptococcal meningitis, and others. Discover the latest research on antifungals here.